Evidence map›Paper›PMID 19011223›Full record

ArticleBlood2009

Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production.

Ludmila Jirmanova, Dandapantula N Sarma, Dragana Jankovic, Paul R Mittelstadt, Jonathan D Ashwell

Open access · greenAbstract read
In one paragraph

Article in Blood, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Gadd45 Proteins in Immunity 2.0.Advances in experimental medicine and biology · 2022
    Article
  3. The p38 Pathway: From Biology to Cancer Therapy.International journal of molecular sciences · 2020
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. TEC and MAPK Kinase Signalling Pathways in T helper (TJournal of clinical & cellular immunology · 2012
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ludmila JirmanovaLaboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Dandapantula N Sarma
Dragana Jankovic
Paul R Mittelstadt
Jonathan D Ashwell
National Cancer Institute · USNational Institutes of Health · USNational Institute of Allergy and Infectious Diseases · US

Funding

T Cell Alternative p38 Activation PathwayZIABC010774 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ASHWELL, JONATHAN · 2009 to 2019
$6.2M
T Cell Alternative p38 Activation PathwayZ01BC010774 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ASHWELL, JONATHAN · 2007 to 2008
$1.3M
Intramural NIH HHS
6 · The paper itself

Abstract

T cells possess a p38 activation alternative pathway in which stimulation via the antigen receptor (T-cell receptor [TCR]) induces phosphorylation of p38alpha and beta on Tyr323. To assess the contribution of this pathway to normal T-cell function, we generated p38alpha knockin mice in which Tyr323 was replaced with Phe (p38alpha(Y323F)). TCR-mediated stimulation failed to activate p38alpha(Y323F) as measured by phosphorylation of the Thr-Glu-Tyr activation motif and p38alpha catalytic activity. Cell-cycle entry was delayed in TCR-stimulated p38alpha(Y323F) T cells, which also produced less interferon (IFN)-gamma than wild-type T cells in response to TCR-mediated but not TCR-independent stimuli. p38alpha(Y323F) mice immunized with T-helper 1 (Th1)-inducing antigens generated normal Th1 effector cells, but these cells produced less IFN-gamma than wild-type cells when stimulated through the TCR. Thus, the Tyr323-dependent pathway and not the classic mitogen-activated protein (MAP) kinase cascade is the physiologic means of p38alpha activation through the TCR and is necessary for normal Th1 function but not Th1 generation.

Indexed as

AnimalsBlotting, WesternCell CycleEnzyme ActivationEnzyme-Linked Immunosorbent AssayFlow CytometryGene Knock-In TechniquesInterferon-gammaIsoenzymesLymphocyte ActivationMicep38 Mitogen-Activated Protein KinasesPhosphorylationReceptors, Antigen, T-CellSignal TransductionTh1 CellsInterferon-gammaIsoenzymesp38 Mitogen-Activated Protein KinasesReceptors, Antigen, T-Cell

Identifiers

PMID19011223
PMCPMC2652368
OpenAlexW2066683216

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.